No items to display
In This Section
- What We Do
- Opioid Continuing Education Program
- Institute Faculty and Staff
- Medical Cannabis Education
Substance Use Disorders Institute
The costs to individuals, families, and our communities have been devastating. Driven in part by excessive opioid use and an unprecedented flood of deadly heroin and fentanyl, drug overdose deaths have skyrocketed, resulting in hundreds of lives lost a day and an epidemic deadlier than the 1990s HIV/AIDS crisis.
About 23 million Americans need treatment for a substance use disorder—less than 10% receive it. And appropriate prevention and support services are needed for those using substances in a problematic way. All healthcare professionals should feel called to action to address the problem, including learning from the over 22 million Americans living in recovery.
Gaps in knowledge and training—in addition to pervasive stigma and discrimination—perpetuate ineffective treatments and policy, and limit positive change. The solution: a research- and evidence-based approach.
The Substance Use Disorders Institute (SUDI) at USciences translates science into policy and practice and improves substance use disorders care, and promote effective long-term recovery strategies.
Our work includes
Improving patient care by educating healthcare professionals about substance use disorder risk factors, prevention, treatment, and recovery. See more information about our medical cannabis certification courses and opioid continuing education programming.
Synthesizing and analyzing scientific evidence.
Providing recommendations to decision-makers to inform healthcare and drug policy choices.
Conducting impactful preclinical, clinical, health policy, and public health research.
With more states requiring healthcare providers to improve their education and credentials, SUDI provides critical training and certification courses. And by convening the top subject matter experts for lecture series and other discussions, SUDI serves as a regional hub for substance use and recovery education, and legislative progress.
5:15pm - 9:30pmRegister here
USciences Substance Use Disorders Institute is proud to offer its Medical Cannabis 4-Hour Certification Course on...
8:00am - 12:15pmRegister here
USciences Substance Use Disorders Institute is proud to offer its Medical Cannabis 4-Hour Certification Course in...
5:15pm - 9:30pmRegister here
USciences Substance Use Disorders Institute is proud to offer its Medical Cannabis 4-Hour Certification Course via...
- Cannabis Makes a Comeback
February 05, 2021
The Substance Use Disorders Institute at USciences is translating science into policy and practice for medical cannabis research and education.
- SUDI Recommends Additional Labeling for Medical Cannabis Products Sold in PA
December 16, 2019
Andrew Peterson, PharmD, PhD, Executive Director of the Substance Use Disorders Institute at USciences went before the Medical Marijuana Advisory Board, the state regulatory body in Pennsylvania, in November to make recommendations about the labeling of medical cannabis products.
- Decoding Substance Use Disorder: Students Shift Perspective During "Life Changing" Conference
July 25, 2019
Described as "by far one of the best decisions I've made in college" by one student, attending the American Pharmacists Association (APhA) Institute on Substance Use Disorders in Salt Lake City, Utah has been an annual experience for students of George Downs PharmD'72 for 31 years.
- Substance Use Discussed at Regional Overdose Prevention Coalition Conference
March 11, 2019
On March 7, dozens of experts in substance use disorders met at USciences for the Regional Overdose Prevention Coalition Conference to talk about the diverse array of issues surrounding the issue.
- Health Policy Student Speaks on Twitter Panel About Intersection Between Technology, Recovery
November 13, 2018
Robert Ashford PhD'24 (Health Policy), MSW, will participate in a multiplatform conversation about recovery and policy that can help to support recovery with @TwitterDC on Wednesday, Nov. 14, 2018, at 4 p.m.